Table of Contents Table of Contents
Previous Page  311 / 471 Next Page
Information
Show Menu
Previous Page 311 / 471 Next Page
Page Background

M

astovska

et al

.:

J

ournal of

AOAC I

nternational

V

ol

.

98, N

o

. 2, 2015 

497

Table 7. Collaborative study results (in µg/kg) obtained by the participating laboratories in blind duplicates fortified at the

mid PAH level in mussel

Laboratory No.

PAH

Sample ID

1

2

3

4

5

6

7

8

9

10

1,7-DMP

SFC M3

5.7

a

48.0

45.9

27.4

46.1

40.5

42.9

43.8

28.2

36.6

SFC M5

39.0

a

38.5

41.7

31.0

44.1

38.9

42.1

57.2

28.8

28.1

1-MN

SFC M3

79.1

92.7

136.2

97.2

95.5

90.3

105.4 110.0 103.5

72.1

SFC M5

78.2

105.0 117.3

87.2

97.2

103.0 109.8 119.5

87.4

50.7

1-MP

SFC M3

60.2

a

55.2

54.3

32.2

52.2

47.1

50.6

50.5

31.5

50.9

SFC M5

870.8

a

41.7

48.0

30.1

49.1

44.9

51.0

63.2

31.7

40.3

2,6-DMN

SFC M3

21.5

a

64.6

69.5

92.3

79.9

63.1

57.6

62.3

43.0

71.7

a

SFC M5

59.2

a

63.6

62.1

85.7

74.9

59.4

61.7

64.0

43.3

92.5

a

3-MC

SFC M3

70.3

81.5

101.6

80.7

93.8

93.4

93.3

91.4

78.6

98.9

SFC M5

69.8

86.6

95.8

70.4

87.4

90.3

95.4

97.3

69.5

96.9

Ant

SFC M3

22.5

17.5

16.5

7.1

8.2

16.5

14.5

13.8

12.3

13.5

SFC M5

14.9

13.6

14.4

11.0

6.6

13.7

14.8

15.2

10.8

14.7

BaA

SFC M3

22.3

21.0

24.8

18.4

21.5

23.2

22.7

22.3

19.6

23.9

SFC M5

22.2

21.3

23.1

16.3

18.8

21.7

23.3

22.3

17.1

23.5

BaP

SFC M3

7.4

9.1

10.0

6.6

6.8

1.1

b

9.2

9.8

7.7

8.4

SFC M5

7.6

8.5

8.8

5.6

5.9

1.1

b

9.4

9.9

6.4

7.8

BbF

SFC M3

28.2

27.3

29.2

24.0

28.9

31.6

27.9

27.6

24.3

29.9

SFC M5

28.3

27.3

27.1

21.0

26.9

25.0

28.4

26.9

21.3

29.8

BghiP

SFC M3

8.8

9.1

10.8

8.1

9.5

9.8

10.0

9.7

7.5

11.0

SFC M5

9.5

9.0

9.8

7.1

8.9

9.3

10.1

9.3

7.3

10.8

BkF

SFC M3

18.7

18.1

22.0

15.2

19.5

21.0

19.3

19.2

16.1

21.9

SFC M5

18.8

18.3

20.0

14.0

18.2

17.2

19.0

18.9

13.9

21.4

Chr

SFC M3

92.7

86.1

100.8

79.7

98.0

95.2

93.2

92.0

86.0

105.2

SFC M5

94.5

91.3

94.0

70.8

91.4

91.7

94.9

95.5

76.0

102.0

DBahA

SFC M3

8.8

9.4

9.7

8.0

9.4

9.9

9.6

9.5

6.3

11.0

SFC M5

8.5

9.2

8.9

7.1

8.8

8.9

10.0

9.5

7.5

11.2

Fln

SFC M3

24.8

25.0

26.8

29.2

25.2

24.9

24.5

24.5

23.9

28.5

SFC M5

24.3

25.6

25.1

29.6

23.6

24.1

25.1

26.0

21.9

26.5

Flt

SFC M3

47.8

45.5

49.7

46.6

50.8

55.3

48.1

48.2

39.2

55.6

SFC M5

53.7

47.6

46.8

42.1

47.2

54.5

49.0

49.5

46.6

53.3

IcdP

SFC M3

9.0

9.6

10.1

8.1

9.7

10.1

9.5

9.7

8.6

11.3

SFC M5

9.5

9.3

9.8

7.2

9.1

9.2

9.9

9.5

6.9

11.4

Naph

SFC M3

91.8

125.4 134.8

84.0

104.1

97.1

124.2 129.6 123.9

71.7

SFC M5

84.6

122.2 127.8

65.1

107.7 114.8 124.8 135.3 109.7

40.0

Phe

SFC M3

92.1 206.3

b

102.0

81.9

102.1

93.7

95.1

94.3

a

84.3

98.8

SFC M5

97.1 191.3

b

93.9

76.3

96.2

90.5

96.6

119.2

a

82.5

107.0

Pyr

SFC M3

79.2

71.9

80.3

62.0

75.6

71.2

72.4

72.2

64.2

80.2

SFC M5

75.4

74.6

75.8

55.5

70.4

69.3

73.3

72.0

58.2

76.7

a

 Outliers removed by the Cochran test.

b

Outliers removed by single Grubbs’ test.

Candidates for 2016 Method of the Year

252